Remove Invention Remove Licensing Remove Patent Infringement Remove Technology
article thumbnail

Patent Licensing is a Risky Business: Let the Market Strike the Balance

IP Watchdog

Patent licensing and technology transfer is a cornerstone of modern economies, where the efficiencies of collaboration and division of labor do not require firms to be vertically integrated. The Wright brothers did not build commercial aviation, and yet commercial aviation was born thanks to the Wright brothers’ invention.

Licensing 120
article thumbnail

COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues

SpicyIP

The mRNA vaccine platform is a versatile vaccine technology that has the potential to treat several diseases. Several intellectual property rights battles are being fought over this new technology. COVID-19 Vaccine Patent Infringement? 2010/144740 and in the 966 patent. We covered Moderna’s complaint here.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Peloton, Lululemon and Nike Patent Infringement Lawsuits: Practical Intellectual Property Considerations

IPilogue

In late November 2021, Lululemon launched a lawsuit for design patent infringement against Peloton in relation to perceived similarities in the design elements of various pieces of activewear, including sports bras and leggings. Secondly, the cases indicate potential strategies a party can use to defend against claims of infringement.

article thumbnail

Historic $130m+ Patent Infringement Award Against the United States of America

Intellectual Property Law Blog

A Sheppard Mullin trial team led by partners Brad Graveline and Laura Burson obtained one of the largest patent infringement damages awards against the United States of America for client SecurityPoint Holdings, Inc (SecurityPoint). SecurityPoint brought its claim for patent infringement against the United States under 28 U.S.C.

article thumbnail

Post-Default Creditor’s Right to Assign, License and Enforce Patent does not Disturb Patentee’s Separate Right to Sue Infringers

Patently-O

May 1, 2024) offers some interesting insight into leveraged patent transactions, and the effect of a lender’s ability to license or assign a patent on the patent owner’s standing to sue for infringement, especially after default. ” IT sued Zebra for infringement in the W.D.Tex.,

article thumbnail

REGENXBIO Sues Sarepta Therapeutics for Patent Infringement on Gene Therapy Product

LexBlog IP

alleging that the defendants’ adeno-associated virus (“AAV”) technology gene therapy product has infringed or will infringe U.S. 11,680,274 (“the ‘274 Patent”). ” The Biologics License Application (BLA) for SRP-9001 was accepted for priority review by the FDA in November 2022.

article thumbnail

Understanding Freedom to Operate (FTO) Concerning IP & Patents

Kashishipr

Three pharmaceutical companies, including Enzon Pharmaceuticals, Micromet AG, and Cambridge Antibody Technology (now acquired by AstraZeneca), in September 2003 announced signing a non-exclusive cross-license agreement. Without any doubt, stepping into patent litigation can be uncertain, full of risks, and expensive.

IP 105